Literature DB >> 16466729

Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia.

Agot Lia Amundsen1, Janette Khoury, Per Ole Iversen, Caroline Bergei, Leiv Ose, Serena Tonstad, Kjetil Retterstøl.   

Abstract

Serum lipids increase during pregnancy. However, data are scarce for lipid changes in pregnant women with heterozygous familiar hypercholesterolemia (FH). The purpose of the present study was to examine plasma lipids and lipoproteins during pregnancy in women with FH. In 22 pregnant women blood samples were collected at gestational weeks 17-20 (baseline), 24, 30 and 36. Total- and LDL cholesterol increased significantly between baseline and gestational week 36 by 29% and 30%, respectively, compared to 25% and 34% in a reference group of 149 healthy pregnant women. Notably, the plasma lipid concentrations in the FH women were much higher than in the reference women. Triglycerides increased (P<0.05) by 116% and 103%, in the FH group and reference group, respectively. HDL cholesterol was unchanged in both groups. Moreover, apolipoprotein B increased significantly during pregnancy in the FH women, whereas apolipoprotein A1 and lipoprotein (a) were unchanged. Pregnancy outcomes in the FH group did not differ significantly from those in the reference group. In conclusion, the relative increase in plasma lipids was similar in pregnant women with FH and in healthy women, but the absolute magnitude was considerably larger in pregnant FH women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466729     DOI: 10.1016/j.atherosclerosis.2006.01.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  Changes in LDL and HDL subclasses in normal pregnancy and associations with birth weight, birth length and head circumference.

Authors:  Aleksandra Zeljkovic; Jelena Vekic; Slavica Spasic; Zorana Jelic-Ivanovic; Vesna Spasojevic-Kalimanovska; Tamara Gojkovic; Daniela Ardalic; Vesna Mandic-Markovic; Nikola Cerovic; Zeljko Mikovic
Journal:  Matern Child Health J       Date:  2013-04

Review 2.  Recommendations for the management of patients with familial hypercholesterolemia.

Authors:  David I Feldman; Michael J Blaha; Raul D Santos; Steve R Jones; Roger S Blumenthal; Peter P Toth; Laurence S Sperling; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

3.  Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk.

Authors:  D Meeike Kusters; Hans J Avis; Marjet J Braamskamp; Roeland Huijgen; Frits A Wijburg; John J Kastelein; Albert Wiegman; Barbara A Hutten
Journal:  J Lipid Res       Date:  2013-07-05       Impact factor: 5.922

Review 4.  Dyslipidemia Management in Pregnancy: Why Is It not Covered in the Guidelines?

Authors:  Joanna Lewek; Maciej Banach
Journal:  Curr Atheroscler Rep       Date:  2022-04-30       Impact factor: 5.967

Review 5.  Cholesterol in pregnancy: a review of knowns and unknowns.

Authors:  Änne Bartels; Keelin O'Donoghue
Journal:  Obstet Med       Date:  2011-07-28

Review 6.  Identification and management of familial hypercholesterolaemia: what does it mean to primary care?

Authors:  Nadeem Qureshi; Steve E Humphries; Mary Seed; Philip Rowlands; Rubin Minhas
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

Review 7.  Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease.

Authors:  Aneesha Thobani; Lauren Hassen; Laxmi S Mehta; Anandita Agarwala
Journal:  Curr Atheroscler Rep       Date:  2021-08-04       Impact factor: 5.113

Review 8.  Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care.

Authors:  Sujana Balla; Eson P Ekpo; Katherine A Wilemon; Joshua W Knowles; Fatima Rodriguez
Journal:  Curr Atheroscler Rep       Date:  2020-08-20       Impact factor: 5.113

Review 9.  Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Authors:  Albert Wiegman; Samuel S Gidding; Gerald F Watts; M John Chapman; Henry N Ginsberg; Marina Cuchel; Leiv Ose; Maurizio Averna; Catherine Boileau; Jan Borén; Eric Bruckert; Alberico L Catapano; Joep C Defesche; Olivier S Descamps; Robert A Hegele; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Jan Albert Kuivenhoven; Luis Masana; Børge G Nordestgaard; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Elisabeth Steinhagen-Thiessen; Erik S Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Olov Wiklund
Journal:  Eur Heart J       Date:  2015-05-25       Impact factor: 29.983

10.  Polymorphisms of CYP51A1 from cholesterol synthesis: associations with birth weight and maternal lipid levels and impact on CYP51 protein structure.

Authors:  Monika Lewińska; Urska Zelenko; Franci Merzel; Simona Golic Grdadolnik; Jeffrey C Murray; Damjana Rozman
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.